Chan, Kwan L.

Effect of Lipid Lowering With Rosuvastatin on Progression of Aortic Stenosis: Results of the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) Trial

Chan, K. L., Teo, K., Dumesnil, J. G., Ni, A., & Tam, J. (2010) · Circulation

Cardiac Valve Diseases and TreatmentsLipoproteins and Cardiovascular Health

Cited by 815

Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis

Capoulade, R., Chan, K. L., Yeang, C., Mathieu, P., Bossé, Y., Dumesnil, J. G., Tam, J. W., Teo, K. K., Mahmut, A., Yang, X., et al. (2015) · Journal of the American College of Cardiology

Cardiac Valve Diseases and TreatmentsAtherosclerosis and Cardiovascular Diseases

Cited by 417

Impact of Metabolic Syndrome on Progression of Aortic Stenosis

Capoulade, R., Clavel, M.-A., Dumesnil, J. G., Chan, K. L., Teo, K. K., Tam, J. W., Côté, N., Mathieu, P., Després, J.-P., & Pibarot, P. (2012) · Journal of the American College of Cardiology

Cardiac Valve Diseases and TreatmentsCardiovascular Function and Risk Factors

Cited by 127

Metabolic Syndrome Is Associated With More Pronounced Impairment of Left Ventricle Geometry and Function in Patients With Calcific Aortic Stenosis

Pagé, A., Dumesnil, J. G., Clavel, M.-A., Chan, K. L., Teo, K. K., Tam, J. W., Mathieu, P., Després, J.-P., & Pibarot, P. (2010) · Journal of the American College of Cardiology

Cardiovascular Function and Risk FactorsCardiac Valve Diseases and Treatments

Cited by 102

Lipoprotein(a) and Calcific Aortic Valve Stenosis Progression: A Systematic Review and Meta-Analysis

Arsenault, B. J., Loganath, K., Girard, A., Botezatu, S., Zheng, K. H., Tzolos, E., Abdoun, K., Tastet, L., Capoulade, R., Côté, N., et al. (2024) · JAMA Cardiology

Cardiac Valve Diseases and TreatmentsAortic Disease and Treatment Approaches

Cited by 80